Related Experiment Video
Updated: Jan 31, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation
Catherine C Fahey1, Ian J Davis1,2
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7295.
Abstract:
The H3 lysine 36 histone methyltransferase SETD2 is mutated across a range of human cancers. Although other enzymes can mediate mono- and dimethylation, SETD2 is the exclusive trimethylase. SETD2 associates with the phosphorylated carboxy-terminal domain of RNA polymerase and modifies histones at actively transcribed genes. The functions associated with SETD2 are mediated through multiple effector proteins that bind trimethylated H3K36. These effectors directly mediate multiple chromatin-regulated processes, including RNA splicing, DNA damage repair, and DNA methylation. Although alterations in each of these processes have been associated with SETD2 loss, the relative role of each in the development of cancer is not fully understood. Critical vulnerabilities resulting from SETD2 loss may offer a strategy for potential therapeutics.
Insights
SETD2, a key enzyme for histone trimethylation, is frequently mutated in human cancers. Its loss impacts RNA splicing, DNA repair, and methylation, presenting potential therapeutic vulnerabilities.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- The SETD2 enzyme is responsible for H3K36 trimethylation, a crucial epigenetic modification.
- SETD2 mutations are prevalent in various human cancers, affecting gene transcription.
- While SETD2 is the sole trimethylase, its precise role in cancer development requires further elucidation.
Purpose of the Study:
- To investigate the functions of SETD2-mediated H3K36 trimethylation.
- To understand the downstream effects of SETD2 loss in cancer.
- To identify potential therapeutic strategies based on SETD2 vulnerabilities.
Main Methods:
- Analysis of SETD2's association with RNA polymerase.
- Investigation of SETD2's role in chromatin regulation.
- Assessment of effector proteins binding to trimethylated H3K36.
Main Results:
- SETD2 modifies histones at actively transcribed genes via association with RNA polymerase.
- SETD2-mediated H3K36 trimethylation regulates RNA splicing, DNA damage repair, and DNA methylation.
- Loss of SETD2 function disrupts these critical cellular processes.
Conclusions:
- SETD2 plays a vital role in maintaining genomic stability and regulating gene expression.
- Understanding the consequences of SETD2 loss is crucial for cancer therapy development.
- Targeting vulnerabilities arising from SETD2 mutations may offer novel therapeutic avenues.
Related Concept Videos
Piaget's Stage 2 of Cognitive Development
Piaget's Stage 1 of Cognitive Development
Exploration...
Piaget's Stage 3 of Cognitive Development
Conservation and Constancy of Quantity
A significant cognitive milestone in the...
Piaget's Stage 4 of Cognitive Development
Abstract Reasoning and Hypothetical-Deductive Thinking
Unlike the concrete operational...
Timing and Consequences on Behavior
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
Setting Time of Cement

